Michael Byrnes Insider Profile

4 Followers
Michael Byrnes, CFO & Treasurer at Ocera Therapeutics, holds 3.12K shares in eFFECTOR Therapeutics (Ticker: EFTR), holds 0.00 shares in Ocera Therapeutics (Ticker: OCRX), holds ― shares in CERo Therapeutics Holdings (Ticker: CERO).
tipranks
Michael Byrnes

Michael Byrnes
Ocera Therapeutics (OCRX)
CFO & Treasurer

Ranked #71,963 out of 99,218 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-16.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$100
100.00%
0.00%
A breakdown of Michael Byrnes's holdings

Insider Roles

eFFECTOR Therapeutics
(EFTR)
CFO
CERo Therapeutics Holdings
(CERO)
Director
Roles that Michael Byrnes holds in companies

Most Profitable Insider Trade

Stock:
Ocera Therapeutics
(OCRX)
Rating:Informative Buy
Date:Jan 19, 2016 - Jan 19, 2017
Return:+1.40%
The most profitable trade made by Michael Byrnes

Michael Byrnes's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
OCRX
Ocera Therapeutics
Dec 11, 2017
Uninformative Sell
247.76K
$0.00
eFFECTOR Therapeutics
May 17, 2024
CFO
Uninformative Buy
2.33K
$99.74
CERo Therapeutics Holdings
Director
List of latest transactions for each holding click on a transaction to see Michael Byrnes's performance on stock

Michael Byrnes insider profile FAQ

What is the percentage of profitable transactions made by Michael Byrnes?
The percentage of profitable transactions made by Michael Byrnes is 25%.
    What is the average return per transaction made by Michael Byrnes?
    The average return per transaction made by Michael Byrnes is -16.30%.
      What stocks does Michael Byrnes hold?
      Michael Byrnes holds: OCRX, EFTR, CERO stocks.
        What was Michael Byrnes’s latest transaction?
        Michael Byrnes latest transaction was an Uninformative Buy of $2.33K.
          What was Michael Byrnes's most profitable transaction?
          Michael Byrnes’s most profitable transaction was an Informative Buy of OCRX stock on January 19, 2016. The return on the trade was 1.40%.
            What is Michael Byrnes's role in Ocera Therapeutics?
            Michael Byrnes's role in Ocera Therapeutics is CFO & Treasurer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.